Alterations in lens protein tyrosine phosphorylation and phosphatidylinositol 3-kinase signaling during selenite cataract formation

Current Eye Research

Volumn 28, Issue 2, 2004, Pages 135-144

  Chandrasekher, Gudiseva ^a,b   Sailaja, Dasetty ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

Author keywords

Cataract; IGF 1; Insulin; Lens; Phosphatidylinositol 3 kinase; Selenium; Tyrosine phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; INSULIN; LENS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHORUS 32; SODIUM SELENITE; SOMATOMEDIN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CORRELATION ANALYSIS; ENZYME ACTIVITY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LENS EPITHELIUM; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STIMULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CATARACT; CELLS, CULTURED; CRYSTALLINS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LENS, CRYSTALLINE; PHOSPHORYLATION; PRECIPITIN TESTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SODIUM SELENITE; TYROSINE;

EID: 1042298097     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.28.2.135.26232     Document Type: Article

References (48)

1. Berman ER. Lens. In: Berman ER, ed. Biochemistry of the Eye. New YorkA: Plenum Press; 1991:201-290.
2. Hunter T. Tyrosine phosphorylation in cell signaling and disease. Keio J Med. 2002;51:61-71.
3. Gibbs JB. Anticancer drug targets: Growth factors and growth factor signaling. J Clin Invest. 2000;105:9-13.
4. Spiegel AM, Weinstein LS, Shenker A. Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest. 1993;92:1119-1125.
5. Cheng Q, Robison GW, Zigler SJ. Geranylgeranyl pyrophosphate counteracts the cataractogenic effect of lovastatin on cultured rat lenses. Exp Eye Res. 2002;75: 603-609.
6. Zhou J, Menko AS. The role of Src family kinases in cortical cataract formation. Invest Ophthalmol Vis Sci. 2002;43:2293-2300.
7. Sheets NL, Chauhan BK, Wawrousek E, Hejtmancik JF, Cvekl A, Kantorow M. Cataract-and lens-specific upregulation of ARK receptor tyrosine kinase in Emory mouse cataract. Invest Ophthalmol Vis Sci. 2002;43: 1870-1875.
8. Gong X, Wang X, Han J, Niesman J, Huang Q, Horwitz J. Development of cataractous macro ophthalmia in mice expressing an active MEK1 in the lens. Invest Ophthalmol Vis Sci. 2001;42:539-548.
9. Rao PV, Robison WG Jr, Bettelheim F, Lin LR, Reddy VN, Zigler JS. Jr. Role of small GTP-binding proteins in lovastatin-induced cataracts. Invest Ophthalmol Vis Sci. 1997;38:2313-2321.
10. Zatechka DS, Kador PF, Garcia-Castineiras S, Lou MF. Diabetes can alter the signal transduction pathways in the lens of rats. Diabetes. 2003;52:1014-1022.
11. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990;61:203-212.
12. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211-225.
13. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655-1657.
14. Chauhan D, Pandey P, Hideshima T, Treon S, Raje N, Davies FE, Shima Y, Tai YT, Rosen S, Avraham S, Kharbanda S, Anderson KC. SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma, cells. J Biol Chem. 2000; 275:27845-27850.
15. Joneson T, Bar-Sagi D. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol Cell Biol. 1999;19:5892-5901.
16. Wang Z, Glick, Zhang L, Moran MF. Requirement for phospholipase c-γl enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol. 1998;18:590-597.
17. Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: Its role in cell growth and disease. Philos Trans R Soc Land B Biol Sci. 1998;353:583-605.
18. Zwick E, Bangs J, Ulrich A. Receptor tyrosine kinase signaling as a target for cancer intervention strategies. Inducer Related Cancer. 2001;8:161-173.
19. Favoni RE, de Cupis A. The role of polypeptide growth factors in human carcinomas: New targets for a novel pharmacological approach. Pharmocol Rev. 2000;52:179-206.
20. Robertson SC, Tynan JA, Donoghue DJ. RTK mutations and human syndromes: When good receptors turn bad. Trends Genet. 2000;16:265-271.
21. Spector A. The search for a solution in to senile cataracts: Proctor Lecture. Invest Ophthalmol Vis Sci. 1984;25:130-136.
22. Stephens LR, Jackson, TR, Hawkins PT. Agonist-stimulated synthesis of phosphatidylinositol (3,4,5)-triphosphate: A new intracellular signaling system? Biochim Biophys Acta. 1993;1179:27-75.
23. Kapeller R, Cantley LC. Phosphatidylinositol 3-Kinase. BioEssays. 1994;16:565-576.
24. Rameh LE, Cantley LC. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem. 1999;274:8347-8350.
25. Chandrasekher G, Bazan HEP. Phosphatidylinositol 3-kinase in bovine lens and its stimulation by insulin and IGF-1. Invest Ophthalmol Vis Sci. 2000;418:44-849.
26. Shearer TR, Ma H, Fukiage C, Azuma M. Selenite nuclear cataract: Review of the model. Mol Vis. 1997;3:8.
27. Ostadalova I, Babicky A, Obenberger J. Cataract induced by administration of a single dose of sodium selenite to suckling rats. Experientia. 1978;34:222-223.
28. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
29. Chandrasekher G, Bazan HEP. Corneal epithelial wound healing increases the expression but not long lasting activation of the p85α subunit of phosphatidylinositol-3 kinase. Curr Eye Res. 1999;18:168-176.
30. Chandrasekher G, Bazan NG, Bazan HEP. Selective changes in protein kinase (PKC) isoform expression in rabbit corneal epithelium during wound healing. Inhibition of corneal epithelial repair by PKCα antisense. Exp Eye Res. 1998;67:603-610.
31. Liu Q, Schacher D, Hurth C, Freund GG, Dantzer R, Kelley KW. Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J Immunol. 1997;159:829-837.
32. Moscatello DK, Holgado-Madruga M, Emlet DR, Montgomery RB, Wong AJ. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem. 1998;273:200-206.
33. Hu P, Margolis B, Skolnik EY, Lammers R, Ullrich A, Schlessinger J. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol. 1992;12:981-990.
34. Kanagasundaram V, Jaworowski A, Hamilton JA: Association between phosphatidylinositol-3 kinase, Cbl and other tyrosine phosphorylated proteins in colony-stimulating factor-1-stimulated macrophages. Biochem J. 1996;320: 69-77.
35. Cenedella RJ, Augusteyn RC. On the composition and origin of the urea-soluble polypeptides of the U18666A cataract. Curr Eye Res. 1992;98:805-818.
36. Watanabe H, Shearer TR. Lens crystallins in aqueous and vitreous humors in selenite overdose cataract. Curr Eye Res. 1989;8:479-486.
37. Tamada Y, Fukiage C, Nakamura Y, Azuma M, Kim YH, Shearer TR. Evidence for apoptosis in the selenite rat model of cataract. Biochem Biophys Res Common. 2000;275:300-306.
38. 2- transport. Curr Eye Res. 1993;12:213-218.
39. Cenedella RJ. Direct biochemical measurement of DNA synthesis and net rates of differentiation of rat lens epithelial cells in vivo: Applied to selenium cataract. Exp Eye Res. 1987;44:677-690.
40. Park HS, Park E, Kim MS, Ahn K, Kim IY, Choi EJ. Selenite inhibits the c-Jun-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism. J Biol Chem. 2000;275:2527-2531.
41. Hei YJ, Farahbakhshian S, Chen X, Battell ML, McNeill JH. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Mol Cell Biochem. 1998;178:367-375.
42. Stapelton SR, Garlock GL, Foellmi-Adams L, Kletzien RF. Selenium: Potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochim Biophys Acta. 1997;1353:259-269.
43. David LL, Shearer TR, Shih M. Sequence analysis of lens β-crystallins suggests involvement of calpain in cataract formation. J Biol Chem. 1993;268:1937-1940.
44. Robinson ML, Crow LAM, Thomson JA, Overbeek PA. Expression of truncated FGF receptor results in defective lens development in transgenic mice. Development. 1995; 121:3959-3967.
45. Roth GS, Joseph JA, Mason RP. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 1995;18:203-205.
46. Chandrasekher G, Sailaja D. Differential activation of phosphatidylinositol 3-kinase signaling during proliferation and differentiation of lens epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:4400-4411.
47. Zatechka SD, Lou MF. Studies of the mitogen-activated protein kinases and phosphatidylinositol-3 kinase in the lens. 1. The mitogenic and stress responses (double dagger). Exp Eye Res. 2002;74:703-717.
48. Sharma KK, Ortwerth BJ. Aminopeptidase III activity in normal and cataractous lenses. Curr Eye Res. 1986;5:373-380.